Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Early intervention and patient education are crucial for managing alopecia areata.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Essential oils may help hair health but lack strong scientific proof and can cause allergic reactions.

Cats with atopic dermatitis often have severe, year-round itching and respond well to certain treatments.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

The article suggests that patients with Frontal Fibrosing Alopecia may have more contact allergies, but it doesn't prove that allergies cause the condition.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Pimecrolimus cream is not effective for treating alopecia areata.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.